Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases

Published:2021-12-29 Issue:3 Volume:117 Page:462-469
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Kappelman Michael D.,Weaver Kimberly N.,Zhang Xian,Dai Xiangfeng,Watkins Runa,Adler Jeremy,Dubinsky Marla C.,Kastl Arthur,Bousvaros Athos,Strople Jenifer A.,Cross Raymond K.,Higgins Peter D.R.,Ungaro Ryan C.,Bewtra Meenakshi,Bellaguarda Emanuelle A.,Farraye Francis A.,Boccieri Margie E.,Firestine A.,Chun Kelly Y.,Fernando Manory,Bastidas Monique,Zikry Michael,Long Millie D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis;Hu;J Clin Virol,2020

2. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives;Ganesh;Clin Epidemiol Glob Health,2021

3. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy;Grasselli;JAMA Intern Med,2020

4. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

5. Interim results of a phase 1-2a trial of Ad26.COV2.S covid-19 vaccine;Sadoff;N Engl J Med,2021

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases;Frontiers in Pharmacology;2024-09-06

2. Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-07

3. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses;Journal of Autoimmunity;2024-04

4. Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2024-02-14

5. Higher and Sustained Cell-Mediated Immune Responses after Three Doses of mRNA COVID-19 Vaccine In Patients with Inflammatory Bowel Disease on Anti-TNF Therapy;Clinical and Translational Gastroenterology;2024-02-13